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great deal of speculation and research has
been devoted to determining whether a relationship
exists between intellectual performance and schizophre-
nia.Kraepelin
1 and Bleuler
2 recognized at the beginning
of the 20th century that deterioration in intellectual per-
formance is a characteristic of schizophrenia patients.
More recently,the study of cognitive deficits in schizo-
phrenia has been expanding rapidly;over just one decade
in the 1990s, the annual publication rate for studies of
cognition and schizophrenia increased almost fivefold.
3
Considerable evidence indicates that cognitive deficits
are a core impairment of schizophrenia,including cross-
sectional and longitudinal studies of cognitive function-
ing of first-episode and chronic schizophrenia patients,
studies of the nonpsychotic relatives of schizophrenia
patients,studies of premorbid cognitive performance in
individuals destined to develop schizophrenia, and
genetic studies that incorporate assessment of interme-
diate phenotypes in patients.The focus of this paper will
be on the magnitude and frequency of the cognitive
impairment in schizophrenia,its origins and relationship
to symptoms,and the relationship between the genetic
basis of schizophrenia and cognition.
Cognitive functioning in 
schizophrenia patients
A large body of evidence demonstrates that cognitive
deviation from population norms is very common among
patients with chronic schizophrenia.Between 75% and
85% of all schizophrenia patients exhibit severe abnor-
mal cognitive functioning.
4,5 Schizophrenia patients have
a marked deficit in general intellectual ability,or IQ,scor-
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Since the time of Kraepelin and Bleuler, it has been rec-
ognized that schizophrenia is associated with a profound
and persistent cognitive impairment. This paper reviews
the major clinical and epidemiological studies of cognitive
functioning in schizophrenia and other psychotic disorders,
and presents several possible models to explain the asso-
ciation between cognitive impairment and psychosis.
Cognitive impairment is present in the majority of patients
with schizophrenia, and, in some, it is already evident in
the premorbid stages of the disorder. This cognitive
impairment is not secondary to psychotic symptoms, neg-
ative symptoms, or socioeconomic status. Cognitive impair-
ment can also be observed in nonpsychotic family mem-
bers of psychotic patients. On the basis of this evidence, it
has been proposed that abnormal cognitive functioning
can be considered as a possible causal risk factor for psy-
chosis. Recent studies assessing the relationship between
genetic background, cognition, brain function, and schiz-
ophrenia are presented here as an outline for future
research.  
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6 The
deficit in general intellectual ability is coupled with
abnormalities in specific neuropsychological functions,
particularly abnormal memory,working memory,atten-
tion,and executive functioning.
5-8
Studies demonstrate that the cognitive deficits (in both
IQ and specific neuropsychological functions) are
already evident in patients after the first psychotic
episode, and are not due to neuroleptic medication.
Saykin et al
8 studied 37 patients who were never exposed
to neuroleptic medication.Patients showed a broad range
of neuropsychological deficits,including deficits in atten-
tion, abstraction, memory, and learning. Patients per-
formed one to three standard deviations below controls.
Mohamed et al
9 studied 94 first-episode patients, of
whom the majority were neuroleptic-naive.The patients
performed between one to two standard deviations
below controls on the majority of cognitive measures,
which included measures of IQ,memory,attention,and
executive functions.Results are similar after treatment
with neuroleptics,although the cognitive deficit may be
slightly milder.Bilder et al
10 administered a comprehen-
sive neuropsychological test battery to 94 first-episode
patients after initial stabilization of psychosis. Patients
were impaired on all 41 measures,with the majority of
deficits exceeding one standard deviation.
Prospective longitudinal studies of schizophrenia patients
following the first episode have suggested stabilization and
even mild improvement over time.Censits et al
11 followed
30 first-episode patients for 19 months.Patients remained
one to two standard deviations below controls on all neu-
ropsychological measures,with no significant change in
performance over time. In another follow-up study, 35
first-episode or recent-onset schizophrenia patients were
administered a comprehensive battery of neuropsycho-
logical tests during index hospitalization and at either 
1- or 2-year follow-up examination.
12 Neuropsychological
deficits remained stable in most domains. Studies with
longer duration of follow-up show similar results.Gold et
al
13 studied 54 first-episode or recent-onset schizophrenia
patients and followed them for 5 years.They found a mod-
est,3-point improvement in IQ,especially in performance
IQ.More specifically,37 subjects improved their perfor-
mance, 13 subjects performed worse, and 4 subjects
showed no change.Change was also evident on specific
neuropsychological measures: attention, memory, and
executive functions slightly improved,and motor speed
deteriorated.DeLisi et al
14 evaluated the longitudinal neu-
ropsychological performance of 20 first-episode patients
at index hospitalization and at 4-year follow-up. The
majority of the neuropsychological test scores did not
change over time;improvement occurred in tests of con-
centration and speed,and overall global functioning.Hoff
et al
15 studied language, executive, memory, processing
speed,and sensory-perceptual functions in 42 patients with
a first hospitalization for schizophrenia or schizophreni-
form disorder at approximate yearly intervals for the first
2 to 5 years of illness. Patients consistently scored one 
to two standard deviations below normal comparison 
subjects on neuropsychological test measures during the 
5-year course of the study. Patients exhibited some
improvement on measures of language, executive func-
tions,and a mild decline in verbal memory.
In their meta-analysis of neuropsychological perfor-
mance in schizophrenia,Heinrichs and Zakzanis
6 found
no significant relationships between IQ deficits and
potential moderators,including symptom severity,age,
education,neuroleptic dose,sample gender composition,
or age of illness onset.The correlations between specific
neuropsychological functions and measures of psy-
chopathology,such as positive or negative symptoms,are
also relatively modest.
8 In line with this observation,
Mohamed et al
9 and Bilder et al
10 reported that worse
neuropsychological performance was only weakly corre-
lated with severity of negative symptoms and neurolep-
tic dose.
Cognitive functioning in relatives 
of schizophrenia patients
Numerous studies have demonstrated that relatives of
patients with schizophrenia exhibit cognitive impairments
that are milder than,yet similar to,those seen in schizo-
phrenia patients.Studies of monozygotic twins discordant
for schizophrenia have found that the nonpsychotic dis-
cordant twins manifested subtle impairments in memory,
attention, abstraction, and IQ.
16-18 Studies of siblings of
patients with schizophrenia yielded similar results:both
schizophrenia patients and their nonschizophrenic siblings
were cognitively impaired compared with normal controls,
and the nonschizophrenic siblings had a performance that
was intermediate between the probands and normal con-
trols.The cognitive deficits of the relatives included impair-
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*For reference throughout the text:a difference in IQ by a magnitude
of one standard deviation corresponds to 15 IQ points.ments in IQ and specific abnormalities in memory,atten-
tion,and abstraction.
19-23These cognitive deficits in rela-
tives were stable over time.
24 Given that the cognitive
abnormalities are also evident in the nonschizophrenic sib-
lings,these abnormalities do not appear to be a result of
longstanding illness;rather,they appear to represent long-
lasting markers of risk for the disorder,and possibly indi-
cate a genetic predisposition.
The origins of the cognitive impairment 
in schizophrenia
It is clear from the studies reviewed above that schizo-
phrenia is coupled with a severe and debilitating cogni-
tive impairment,which is persistent and independent of
positive or negative symptoms,and does not respond to
neuroleptic treatment.However,cognitive impairments
are also found in other,nonpsychotic psychiatric disor-
ders,though they may be less severe than those seen in
schizophrenia.
25-27Thus,a number of investigators have
sought to determine whether lower cognitive function-
ing occurs as a precursor to, or risk factor for, schizo-
phrenia or only occurs concomitantly with the overt
expression of the illness.A review of these early studies,
mainly in clinical samples,can be found in Alyward et al.
28
Below,I shall describe the main epidemiological studies
addressing the relationship between childhood and ado-
lescence cognitive functioning and later schizophrenia.
Epidemiological samples are representative of the pop-
ulation,and therefore protect against the ascertainment
bias that often affects clinical samples.
Schizophrenia in the British 1946 birth cohort
A study of 5362 British subjects born in March 1946 has
yielded 30 cases of narrowly defined (Diagnostic and
Statistical Manual of Mental Disorders, Third Edition,
Reivsed [DSM-III-R] criteria) schizophrenia up to age
43 years.
29 Compared with the rest of the cohort,those
subjects who went on to develop schizophrenia had
lower cognitive functioning.Specifically,educational test
scores at ages 8, 11, and 15, adjusted for sex and social
class,were consistently lower for the preschizophrenia
group.Approximately half of future patients were in the
lowest tertile of performance on the cognitive tests.
Deficits were particularly noted in verbal,nonverbal,and
mathematical skills,and were independent of ratings of
behavior.
Dunedin multidisciplinary health and development
study
This study followed a 1-year birth cohort of 1037 children
born in Dunedin, New Zealand, from birth to age 26.
30
The authors found that the 36 future patients (defined as
individuals with a schizophreniform disorder) performed
worse than controls on standard IQ tests at each of five
assessments between age 3 and 11 years.The cognitive
deficits were present only among children later diag-
nosed as having schizophreniform disorder, but not in
those later diagnosed with other nonpsychotic psychiatric
disorders,and were independent of the effects of socioe-
conomic and obstetric factors.
Philadelphia cohort of the national collaborative 
perinatal project
Seventy-two patients with schizophrenia or schizoaffec-
tive disorder and 7941 controls with no diagnosis were
found in a birth cohort (originally collected between 1959
to 1966) whose members had been evaluated with stan-
dardized tests of intelligence at 4 and 7 years of age.
31
Adult psychiatric morbidity was ascertained via a longi-
tudinal treatment database indexing regional public
health service utilization,and diagnoses were made by
review of all pertinent medical records according to
DSM-IV criteria.Patients with schizophrenia performed
significantly worse than controls on IQ tests at 4 and 7
years of age.
Schizophrenia in the 1949 to 1950 Swedish conscript
study
Another cohort comprised of some 50 000 Swedish male
conscripts.
32 Baseline assessment of cognitive functioning
was collected at conscription.Cases were identified over
13 years from the Swedish national register of psychiatric
care (International Classification of Diseases,8th Edition
[ICD-8] diagnoses).One hundred and ninety-five cases
of schizophrenia and 192 cases of other psychoses were
identified.Cognitive testing at age 18 showed a signifi-
cant relationship between low IQ scores and later schiz-
ophrenia.A similar,yet weaker,association was observed
for cases with other psychoses.Cognitive deficits were
independent of ratings of social withdrawal, socioeco-
nomic status,drug abuse,or family history of psychiatric
disorders.
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33Schizophrenia in the Israeli conscript study
A case-control study on schizophrenia was nested within
a cohort of male conscripts into the Israeli army between
1985 and 1991.
33,34 Data from cognitive tests at conscrip-
tion were linked to a national case register (ICD-10 diag-
noses) up to 1995,resulting in a comparison between 509
men healthy at conscription but who later developed
schizophrenia,and 9215 men who did not appear in the
register,matched according to age at follow-up and the
type of school attended.Deficits in cognitive functioning
assessed at conscription strongly predicted later schizo-
phrenia.Cognitive deficits were independent of ratings
of social withdrawal.Premorbid cognitive deficits were
evident in future schizoaffective patients,but not in those
with a diagnosis of nonaffective psychosis.
Summary of studies of cognitive impairment and 
schizophrenia
Despite differences in methods of case ascertainment,
use of diverse cognitive tests, and differences in times
when the cohorts were established and geographical
areas,the studies described above consistently show that
low premorbid cognitive functioning is associated with
increased risk for schizophrenia and other psychotic dis-
orders.It is,however,unclear whether these manifesta-
tions are themselves part of a causal pathway to psy-
chosis,or merely indicate vulnerability.
Is cognitive impairment a causal risk factor?
How then should we account for the observed relation-
ship between low cognitive functioning and psychosis? A
Basic research
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Figure 1. Diagrams illustrating relationships between cognitive function and psychosis: (A) abnormal cognitive functioning as a confounder; (B) inde-
pendent causes, including abnormal cognitive functioning, associated with the development of psychosis; (C) causes of psychosis with abnor-
mal cognitive functioning lying on a causal pathway; and (D) abnormal cognitive functioning lying on a causal pathway, but other direct path-
ways also operate.
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Genesdominant view about the etiology of schizophrenia is the
so-called neurodevelopmental hypothesis,suggesting that
schizophrenia arises from early,possibly fetal abnormal-
ities of genetic and/or environmental origin.
35,36 David et
al
32 discussed three possible explanations corresponding
to the neurodevelopmental hypothesis: low cognitive
functioning may be a confounder, may be an indepen-
dent cause,or may indeed lie on the causal pathway.
Confounding factor
It might be argued that the abnormal functioning merely
reflects the prodrome to the illness. However, this is
highly unlikely since the association between low cogni-
tive functioning and schizophrenia was evident even in
individuals first admitted up to 10 years after assess-
ment. Furthermore, no association has been found
between age of onset and the severity of premorbid cog-
nitive impairment.
30,32,33Alternatively,genes predisposing
to psychosis and/or early brain damage may cause brain
abnormalities, which, among other things, also cause
abnormal cognitive functioning (Figure 1A).A number
of conditions that impair cognitive functioning are also
associated with increased risk of psychotic symptoms,
including Huntington’s disease, Alzheimer’s disease,
traumatic brain injury,multiple sclerosis,and epilepsy.
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Furthermore,cognitive functioning shows a relationship
with other possible risk factors for schizophrenia, such
as low birth weight.
38,39 Twin and family studies,
16,23 how-
ever,indicate that,even when the effects of genetic risk
and prenatal environment are controlled,the association
between abnormal cognitive functioning and psychosis
remains. Cannon et al
30 further demonstrated that the
low premorbid cognitive functioning in future patients
was independent of the effects of obstetric factors.
Independent cause
Abnormal cognitive functioning itself might increase the
risk for later psychosis.Individuals with mental handicap
are at increased risk of psychosis.
40 However,considering
that, in the general population, most individuals with
abnormal cognitive functioning do not develop psychosis
(ie,abnormal cognitive functioning has poor positive pre-
dictive value),other risk factors must also be involved
(Figure 1B).
Causal pathway
Most, if not all, putative risk factors for schizophrenia
show a relationship with lower cognitive performance.
So-called “high-risk”studies have consistently reported
that children of patients with schizophrenia perform
worse on intelligence tests than children of nonschizo-
phrenic parents.
28,41,42 Obstetric and birth complications
are another example.
38Thus,the third model suggests that
abnormal cognitive functioning could be the means by
which other genetic and/or environmental influences
increase the risk for psychosis (Figure 1C).Since not all
schizophrenia patients have cognitive impairment,and a
number of different genes may contribute to risk for psy-
chosis,it is likely that there are also direct pathways from
genes and the environment to psychosis (Figure 1D).
Cognitive model
The processes described in the previous sections do not,
however,offer an explanation of how abnormal cognitive
functioning affects the development of psychosis.
Abnormal cognitive functioning could interfere with infor-
mation processing at various levels and domains leading
eventually to the psychopathology of schizophrenia.A
person’s abnormal cognition impairs his or her ability to
comprehend the complexities of society,which could lead
to misunderstandings,feelings of paranoia,and social with-
drawal.
32 Deficits in social cognition are certainly well rec-
ognized in patients with schizophrenia.Abnormal cogni-
tive processes may also interact with a developmental
process induced by genes or environment.
43This abnormal
cognitive process will induce behavior that will itself tend
to alter the environment in which an individual functions,
leading to altered experience and further abnormality in
the developmental process.
Genes for cognition and schizophrenia?
The relationship between impaired cognition and schiz-
ophrenia has led several investigators to suggest target-
ing cognitive functioning as an intermediate phenotype
(or endophenotype) rather than clinical diagnosis.This
would reduce heterogeneity in genetic studies,
23 since
cognitive abnormalities may be more directly related to
the biological effects of susceptibility genes (as proposed
by the models in Figures 1C and 1D and discussed in the
previous section).
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to study the genetic basis of schizophrenia and cognition.
One especially promising finding is evidence implicating
frontal dopamine system dysfunction in the pathogene-
sis of schizophrenia.
44 The gene for catecholamine O-
methyltransferase (COMT) codes for one of the major
enzymes catalyzing the metabolism of dopamine.It has
been mapped to chromosomal region 22q11, and con-
tains a functional polymorphism (Val158Met) that results
in two common variants of the enzyme (Val and Met)
corresponding to high and low dopamine catabolism,
respectively.The COMT gene has been examined several
times for an association with schizophrenia.Although not
conclusive,family-based association studies and case-con-
trol studies do support the claim that variability of this
gene could constitute a risk factor for schizophrenia,
specifically the Val allele.
45 Studies of healthy individuals,
and schizophrenia patients have further demonstrated
that the COMT genotype is related in an allele dosage
fashion to performance on tests of working memory and
executive functions, with more Met alleles associated
with better performance.
46-48 Egan et al
46 also examined
the effect of COMT genotype on prefrontal physiology
during a working memory task using functional magnetic
resonance imaging (MRI).Met allele load consistently
predicted a more efficient physiological response in pre-
frontal cortex.Thus,according to these results,the high
levels of dopamine in individuals with the Met/Met geno-
type enhance prefrontal function and therefore cognitive
performance,and are also associated with lower risk for
psychosis (Figure 2).
Conclusion
The evidence reviewed in this paper strongly supports
the view that cognitive deficits are a risk factor for schiz-
ophrenia and other psychotic disorders.Cognitive deficit
is a stable, “trait-like” condition, independent of psy-
chotic symptoms and mostly unaffected by antipsychotic
treatments. In some patients, it is evident many years
before psychotic symptoms are expressed and,after the
onset of psychotic symptoms,cognitive deficits are pre-
sent in the large majority of patients.Future studies of
the genetic basis of specific cognitive functions and the
association between genes,cognition,and brain processes
will undoubtedly help better understand the role of cog-
nition in the development of psychotic illness. ❏
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Figure 2. Schematic representation of the putative effect of a schizo-
phrenia susceptibility gene (COMT) on neurotransmission and
the relationship with cognition and psychosis. COMT polymor-
phisms effect dopamine regulation in the frontal lobes, through
which cognitive processes are effected. Dopamine dysregulation
increases risk to psychosis either directly, and/or through
impaired cognitive processes. COMT, catecholamine O-methyl-
transferase.
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